Skip to main content
HealthSingle-sourceMedium
5.0

Costa Rica drug access lag hits 7.3 years, above regional average

The WAIT 2026 study shows Costa Rican patients wait 7.3 years for new medicines, up from prior years and above the regional average. This reflects regulatory and reimbursement bottlenecks, likely worsening health outcomes and raising pressure on the health system.

El Financieroabout 18 hours agoCRCredibility 29%View source

Score Breakdown

Mosaic Score5.0
Confidence0.5
Significance0.5
Source credibility0.3
Source

Related signals

8 found